Nighttime blood pressure surges double death risk in diabetic adults

A 21-year study of diabetic adults in Italy has identified a dangerous nocturnal pattern: when blood pressure rises during sleep instead of falling, the risk of death roughly doubles. Researchers presented the findings in September 2021 at the American Heart Association's Hypertension Scientific Sessions, drawing on two decades of data from 349 people with type 1 or type 2 diabetes living in Pisa.

Blood pressure normally declines when we sleep—a phenomenon called "dipping." But not everyone's body follows this rhythm. Some people experience "non-dipping," where nighttime pressure fails to drop the expected 10 percent or more. Others experience something more alarming: "reverse dipping," where blood pressure actually climbs at night relative to daytime levels. The study found that reverse dippers faced more than double the mortality risk of those with normal dipping patterns over the 21-year period. They also lost an average of 2.5 years of life compared to dippers, while non-dippers lost roughly 1.1 years.

The research team, led by investigator Martina Chiriacò from the University of Pisa's department of clinical and experimental medicine, tracked 349 adults—half women, 284 with type 2 diabetes and 65 with type 1. All underwent 24-hour ambulatory blood pressure monitoring. The cohort was notably sick: 82 percent had hypertension, and 73 percent had uncontrolled high blood pressure despite taking medication. Over the two decades through 2020, 136 participants died.

What emerged from the data was striking. More than half the group showed non-dipping patterns at night. One in five were reverse dippers. And reverse dippers carried a particular burden: nearly one-third had cardiac autonomic neuropathy, a serious diabetes complication in which nerves controlling the heart and blood vessels deteriorate, disrupting the regulation of blood pressure and heart rate. Only 11 percent of those with normal dipping patterns had this nerve damage. Reverse dippers were also more likely to be older and to show signs of hypertension-related heart damage.

The study also examined heart rate variability—the natural variation in time between heartbeats—as a marker of cardiovascular health. People with low heart rate variability lost an average of 1.8 years of survival. This measure, like abnormal blood pressure dipping, reflects dysfunction in the autonomic nervous system, the body's automatic control center for vital functions.

Chiriacò emphasized that the findings point toward a practical solution. Ambulatory blood pressure monitoring—a portable device that records pressure throughout the day and night—is inexpensive and widely available. It can identify these dangerous patterns and guide treatment decisions. "There are strategies to reduce blood pressure during the night," she noted, suggesting that screening could help doctors optimize care for diabetic patients at highest risk.

The study does carry limitations. Researchers did not establish whether participants had existing cardiovascular disease at the start, which could have clarified whether abnormal dipping patterns pose equal risk to everyone or whether those with prior heart problems face steeper odds. The cohort was also predominantly white, and the researchers acknowledged that non-dipping is more common among people of African or Hispanic descent—meaning the findings need validation in more diverse populations before they can be confidently applied across all groups.

Still, the core message is clear: one in ten people with type 1 or type 2 diabetes may be a reverse dipper, and that condition likely more than doubles their risk of death from any cause over two decades. For a disease that already carries substantial mortality risk, identifying this subset through simple screening could reshape how doctors approach nighttime blood pressure management.